PRBUZZ: Press Release News Wire

Friday
Mar 19th
Text size
  • Increase font size
  • Default font size
  • Decrease font size

CollegeStock.com: The Dean's Upper-Class Picks of the Day Featuring APNT, XMCP, SLGLF and IVOB

E-mail Print PDF
The Dean of http://CollegeStock.com’s Upper-Class Picks of the Day are Applied Nanotech Holdings, Inc. (OTCBB: APNT), Xiom Corporation (OTCBB: XMCP), Silverado Gold Mines Ltd. (OTCBB: SLGLF) and INVO Bioscience (OTCBB: IVOB).

Applied Nanotech Holdings, Inc. (OTCBB: APNT)
On Monday, August 24, 2009, Applied Nanotech Holdings, Inc. (OTCBB: APNT) announced that the formation of a special advisory committee to the Board of Directors which will assist in formulating and implementing business development initiatives.

Xiom Corporation (OTCBB: XMCP)
Xiom Corporation (OTCBB: XMCP) announced today announced that they recently came to an agreement with Orica Power & Industrial Coatings to further expand a previously arranged distribution accord.

Silverado Gold Mines Ltc. (OTCBB: SLGLF)
Silverado Gold Mines Ltd. (OTCBB: SLGLF) released news of the creation of an advisory board and named Mr. Peter Hooper as its first member today.

INVO Bioscience (OTCBB: IVOB)
INVO Bioscience (OTCBB: IVOB), a company engaged in the development of infertility treatments for use around the world, was discussed in a thorough company analysis by Eric Sebastien of StocksHaven Investments yesterday. INVO Bioscience currently marketing their principal product, the INVOcell, to countries with high fertility rates all around the world. While the INVOcell device has already received CE Mark Approval in Europe, INVO Bioscience is working to raise funds for a study required for FDA approval in the United States.

Eric Sebastien quotes INVO Bioscience CEO Katie Karloff’s discussing the potential of forming further distribution agreements:

We are thrilled by the positive response from distributors to assist INVO Bioscience in launching the INVO procedure in South America. The availability of the INVO procedure in both stand-alone centers and existing IVF centers reaffirms that this breakthrough does not compete with IVF, but instead is a new option that will greatly increase access to treatment to the 150 million infertile couples worldwide.

Sebastien, who has 15 years of experience in the stock exchange, suggested that INVO Bioscience could stand to see $4 billion in revenue when they capture a mere 5% of the infertility market with their INVOcell device and INVO procedure. The full article can be found at http://seekingalpha.com/article/157805-invo-bioscience-giving-birth-to-a-profitable-company.

ABOUT INVO BIOSCIENCE
INVO Bioscience (IVOB) is a medical device company, headquartered in Beverly, Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. The company’s lead product, the INVOcell, is a novel medical device used in infertility treatment that enables egg fertilization and early embryo development in the woman’s vaginal cavity. The company was founded by Claude Ranoux, MD, a noted expert in the field of reproductive health, infertility and embryology. For more information, please visit www.invobioscience.com.

ABOUT THE COLLEGESTOCK GROUP
The CollegeStock Group, Inc. is the owner of http://CollegeStock.com [CollegeStock.com]. CollegeStock.com is the Internet’s #1 destination for stock market education. With a network of over 100,000 followers, CollegeStock.com focuses on speculative investing into penny stocks. Staying true to their motto of “Higher Learning for a Higher Net Worth,” CollegeStock.com is committed to focusing on real world methods on making money in the stock market and continues to be a reliable source for the best stock picks on the Internet. The Dean features daily commentary on his Ivy League stocks and also features Micro Cap Movies, Class Trip Documentaries, research reports and more. To feature a company on CollegeStock.com, please contact The Dean at Dean@CollegeStock.com.

NOT A BROKER/DEALER OR FINANCIAL ADVISOR
CollegeStock Group, Inc. is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company’s website, or in its publications, are made as of the date stated and are subject to change without notice.

DETAILS OF COMPENSATION RECEIVED
Affiliates of CollegeStock Group, Inc. been compensated two hundred thousand shares of INVO Bioscience (IVOB) from a 3rd party (Lionshare Ventures LLC) and we expect to receive an additional one million shares of IVOB to provide corporate communications services to the company.